Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 31961 questions Show Answers

Order by |

Question reference: S6T-00415

Asked by: Colin Smyth, MSP for South Scotland, Scottish Labour
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 11 January 2022

To ask the Scottish Government whether it will provide an explanation of its decision not to proceed with the sale of Glasgow Prestwick Airport at the present time.

Question reference: S6T-00399

Asked by: Gillian Martin, MSP for Aberdeenshire East, Scottish National Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 11 January 2022

To ask the Scottish Government how it will assist young people to access the expanded free bus travel scheme.

Question reference: S6F-00665

Asked by: Brian Whittle, MSP for South Scotland, Scottish Conservative and Unionist Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

To ask the First Minister what data the Scottish Government has collected on the number of people diagnosed with cancer, and the stage at which they were diagnosed, since the start of the COVID-19 pandemic, and how this compares with pre-pandemic data.

Question reference: S6F-00662

Asked by: Christine Grahame, MSP for Midlothian South, Tweeddale and Lauderdale, Scottish National Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

To ask the First Minister what support the Scottish Government can provide to people struggling to pay their energy bills.

Question reference: S6F-00650

Asked by: Kenneth Gibson, MSP for Cunninghame North, Scottish National Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

To ask the First Minister what steps the Scottish Government will take to urgently progress the green transition in North Ayrshire, following the closure of Hunterston B power station on 7 January.

Question reference: S6F-00639

Asked by: Oliver Mundell, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

To ask the First Minister what deadline the Scottish Government has set for making any further changes to this year's SQA examinations process.

Question reference: S6F-00636

Asked by: Anas Sarwar, MSP for Glasgow, Scottish Labour
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

Question to be taken in Chamber.

Question reference: S6F-00635

Asked by: Douglas Ross, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
Date lodged: Monday, 10 January 2022
Current Status: Taken in the Chamber on 13 January 2022

Question to be taken in Chamber.

Question reference: S6W-05334

Asked by: Monica Lennon, MSP for Central Scotland, Scottish Labour
Date lodged: Wednesday, 22 December 2021
Current Status: Answered by Humza Yousaf on 10 January 2022

To ask the Scottish Government what discussions it has had regarding the drug, sapropterin, being made available to patients in Scotland with phenylketonuria (PKU).

The Scottish Government notes the updated National Institute for Health and Care Excellence (NICE) guidance on sapropterin published September 2021 following a resubmission by its manufacturer Biomarin. The Scottish Medicines Consortium (SMC) previously considered sapropterin (Kuvan) in August 2018 and the medicine was not recommended for use in NHSScotland because the submitting company’s justification of the treatment’s cost in relation to its health benefits was not sufficient and in addition the company did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC. The submitting company (BioMarin) has not been in contact with SMC regarding a resubmission for this medicine.

The first generic version of sapropterin has received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). To support ensuring best value for NHSScotland, NSS National Procurement will shortly be tendering for the future supply of sapropterin to NHS Scotland.

Given the launch of the first generic, we are currently considering how best to provide advice to Health Boards on whether sapropterin should be made available for routine use in NHSScotland, based on the latest available evidence.

Question reference: S6W-05332

Asked by: Beatrice Wishart, MSP for Shetland Islands, Scottish Liberal Democrats
Date lodged: Wednesday, 22 December 2021
Current Status: Answered by Michael Matheson on 10 January 2022

To ask the Scottish Government, further to the answer to question S6W-03602 by Michael Matheson on 25 October 2021, whether it will publish the written report by Seagreen Wind Energy Limited in respect of unexploded ordnance clearance activities.